Patents by Inventor Yatendra Kumar Gupta

Yatendra Kumar Gupta has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10485812
    Abstract: The lyophilized solid pharmaceutical compositions comprising a compound of Formula (I) or a stereoisomer or a pharmaceutically acceptable derivative thereof are disclosed.
    Type: Grant
    Filed: January 11, 2017
    Date of Patent: November 26, 2019
    Assignee: WOCKHARDT LIMITED
    Inventors: Bhaskar Chauhan, Rajendra Nandlal Nagori, Yatendra Kumar Gupta
  • Publication number: 20180028549
    Abstract: The lyophilized solid pharmaceutical compositions comprising a compound of Formula (I) or a stereoisomer or a pharmaceutically acceptable derivative thereof are disclosed.
    Type: Application
    Filed: January 11, 2017
    Publication date: February 1, 2018
    Applicant: WOCKHARDT LIMITED
    Inventors: Bhaskar CHAUHAN, Rajendra Nandlal NAGORI, Yatendra Kumar GUPTA
  • Publication number: 20160243182
    Abstract: The present invention relates to an extract of Cissampelos pareira, its pharmaceutical compositions, and its therapeutic use in the prevention and treatment of dengue. It also relates to processes for the preparation of these extracts.
    Type: Application
    Filed: March 22, 2016
    Publication date: August 25, 2016
    Inventors: Pradip Kumar BHATNAGAR, Chandra Kant KATIYAR, Navin KHANNA, Poornima TYAGI, Dilip Jatashankar UPADHYAY, Sathyamangalam SWAMINATHAN, Kona SRINIVAS, Navin Kumar SHARMA, Anil KANAUJIA, Ruchi SOOD, Tarani Kanta BARMAN, Smita SINGHAL, Gyanesh SHUKLA, Rajeev DUGGAR, Pawan Kumar PAREEK, Yatendra Kumar GUPTA, Yogendra SINGH, Seema KHAN, Rajendra RAUT, Raj Kumar SHIRUMALLA, Vijay KANOJE, Ramesh SUBBARAYAN, Ravisankar RAJERETHINAM
  • Patent number: 8895065
    Abstract: There is provided a single unit oral dose pharmaceutical composition comprising a) levodopa or salts thereof from about 50 mg to about 300 mg in extended release form, b) carbidopa or salts thereof from about 10 mg to about 100 mg in extended release and c) entacapone or salts thereof from about 100 mg to about 1000 mg in immediate release form, optionally with other pharmaceutically acceptable excipients. The invention also relates to process of preparation of such compositions.
    Type: Grant
    Filed: May 29, 2012
    Date of Patent: November 25, 2014
    Assignee: Wockhardt Ltd.
    Inventors: Yatendra Kumar Gupta, Girish Kumar Jain, Munish Talwar, Manoj Mashalkar
  • Publication number: 20120231051
    Abstract: There is provided a single unit oral dose pharmaceutical composition comprising a) levodopa or salts thereof from about 50 mg to about 300 mg in extended release form, b) carbidopa or salts thereof from about 10 mg to about 100 mg in extended release and c) entacapone or salts thereof from about 100 mg to about 1000 mg in immediate release form, optionally with other pharmaceutically acceptable excipients. The invention also relates to process of preparation of such compositions.
    Type: Application
    Filed: May 29, 2012
    Publication date: September 13, 2012
    Inventors: Yatendra Kumar GUPTA, Girish Kumar Jain, Munish Talwar, Manoj Mashalkar
  • Publication number: 20110229566
    Abstract: There is provided a single unit oral dose pharmaceutical composition comprising a) levodopa or salts thereof from about 50 mg to about 300 mg in extended release form, b) carbidopa or salts thereof from about 10 mg to about 100 mg in extended release and c) entacapone or salts thereof from about 100 mg to about 1000 mg in immediate release form, optionally with other pharmaceutically acceptable excipients. The invention also relates to process of preparation of such compositions.
    Type: Application
    Filed: August 22, 2009
    Publication date: September 22, 2011
    Inventors: Yatendra Kumar Gupta, Girish Kumar Jain, Munish Talwar, Manoj Mashalkar